Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fundus Imaging Changes in Uveitis Treated with Fluocinolone Acetonide Intravitreal Implant
ChiCTR2600130784Phase 4Not yet recruiting
- Sponsor
- General Hospital of Central Theater Command of the Chinese People's Liberation Army
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluocinolone in noninfectious uveitis (NIU), sponsored by General Hospital of Central Theater Command of the Chinese People's Liberation Army. Primary endpoints: Central subfield thickness, Vessel density of macular capillary plexus and 1 more. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
fluocinolone
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on ChiCTR2600130784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130784.